System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Francesca Gianno is an expert in Oncology at Istituto Neurologico Mediterraneo (Italy). Francesca Gianno has authored 90 publications, the most recent in 2026. SLR score: 197 (community average: 125). How the SLR is computed.

LeadR Profile

Francesca Gianno Istituto Neurologico Mediterraneo Italy
197 ScienceLeadR Reputation 197

Unlock

Register Login
Network Map

Oncology

Subspecialties: Neurology - Genetics - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026
Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 90

Citations

Citations: 742 1st author: 6 Last author: 2 Unique author: 0

Main journals

Neuro Oncol 11
Cancers (Basel) 4
J Neurooncol 4
Pathologica 4
Endocr Pathol 3

Best Journals

Mol Cancer 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Network based approach identifies miR-145-3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma.
PMID 42713718 — cells, genes, micrornas, neoplasms, pathology, thyroid gland		J Pathol20260
Surgery and radiotherapy strategies at first relapse of pediatric intracranial ependymoma: an Italian retrospective study integrating molecular subgrouping.
PMID 42032119 — radiotherapy, retrospective studies, ependymoma		J Neurooncol20260
Modeling pediatric low-grade glioma heterogeneity using human forebrain organoids.
PMID 41923199 — glioma, neoplasms, organoids, prosencephalon		Mol Cancer Top journal20260
Ageing and pituitary neuroendocrine tumours (PitNETs): from bench to bedside.
PMID 41849686 — aged		Endocr Relat Cancer20260
Life-Threatening Radiation Necrosis After Complete Response to Pembrolizumab in a Patient With a Metastatic Silent PIT1 Pituitary Neuroendocrine Tumor (PitNET).
PMID 41725077 — cells, radiosurgery, neoplasms, immune checkpoint inhibitors, necrosis, neuroendocrine tumors, therapeutics		J Immunother20260

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS